Dermatitis, Atopic: all 1,443 studies
Page 9 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.
- This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)CompletedNCT05608343Phase 3
- Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With DupilumabCompletedNCT05602207Phase 4
- The Transcriptomic Study of Thai Patients With Atopic Dermatitis by Tape StripsStatus unknownNCT05598762Not applicable
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age InclusiveCompletedNCT05590338Phase 1
- Atopic Dermatitis With Accelerometry and Polysomnography (ADAP)CompletedNCT05583019
- A Study of CM310 in Children Patients With Moderate-to-severe Atopic DermatisCompletedNCT05579925Phase 2
- Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic DermatitisStatus unknownNCT05578482Phase 4
- A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic DermatitisCompletedNCT05571943Phase 3
- Bodewell Products for the Treatment of Atopic DermatitisActive, not recruitingNCT05566262Phase 4
- A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisActive, not recruitingNCT05559359Phase 3
- Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic DermatitisCompletedNCT05544591Phase 2
- In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory DiseasesCompletedNCT05544448Not applicable
- Efficacy Evaluation and Cutaneous Acceptability of the Lipikar Med Product on Subjects With Atopic DermatitisCompletedNCT05531188
- A Study to Evaluate the Quality of Life of Male and Female Adult Patients With Severe Refractory Atopic Dermatitis Treated With Dupilumab in Czech RepublicCompletedNCT05527964
- A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic DermatitisActive, not recruitingNCT05526222Phase 3
- Therapist-guided vs Self-guided CBT for AD: Non-inferiority TrialCompletedNCT05517850Not applicable
- Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)Active, not recruitingNCT05509023Phase 2
- Targeting Staphylococci in Atopic DermatitisStatus unknownNCT05502185
- Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical TrialsActive, not recruitingNCT05492578Phase 2/3
- A Clinical Trial of BMX-010 in Adult Subjects With Atopic DermatitisTerminatedNCT05491447Phase 2
- Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic DermatitisCompletedNCT05487963Phase 1/2
- Clinical Relevance of Scratching and Sleep in Atopic DermatitisCompletedNCT05467046
- A Study of MG-K10 in Subjects With Atopic DermatitisActive, not recruitingNCT05466877Phase 2
- Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%CompletedNCT05461456Phase 1
- A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema.CompletedNCT05454722Not applicable
- A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral UpadacitinibCompletedNCT05451316
- Clinical Trial to Evaluate the Effect of a Probiotic Mixture in the Treatment of Atopic Dermatitis in ChildrenTerminatedNCT05443490Not applicable
- A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in TaiwanCompletedNCT05442645
- Effects of Fucoidan on the Gut Microbiota in the Patients of Atopic DermatitisStatus unknownNCT05437887Not applicable
- Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic DermatitisCompletedNCT05432596Phase 2
- An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing DupilumabCompletedNCT05394792
- Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)CompletedNCT05388760Phase 2
- A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.Active, not recruitingNCT05387980
- Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic DermatitisTerminatedNCT05387707Phase 3
- A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic DermatitisCompletedNCT05383378Phase 1
- A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic DermatitisTerminatedNCT05382819Phase 1
- Effects of Tralokinumab in the Skin: an Immunologic and Molecular InvestigationTerminatedNCT05378698Phase 2/3
- IL-4 and Insulin Resistance for Treatment of Patients With Atopic DermatitisCompletedNCT05372003Early Phase 1
- Atopic Dermatitis: Sub-Saharan Africa vs. Central EuropeCompletedNCT05363904
- Phase III Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Atopic DermatitisStatus unknownNCT05326672Phase 3
- Tacrolimus Versus Hydrocortisone in Atopic DermatitisCompletedNCT05324618Phase 4
- Evaluation of an Adapted Formula on Atopic Dermatitis.Active, not recruitingNCT05318300Not applicable
- A Study of Orally Administered IPG7236 in Healthy Adult ParticipantsTerminatedNCT05288543Phase 1
- Probiotic on Atopic Dermatitis in InfantCompletedNCT05286047Not applicable
- A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)CompletedNCT05277571Phase 1/2
- Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children StudyCompletedNCT05276323Phase 2
- A Study of CM310 in Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT05265923Phase 3
- Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.Status unknownNCT05265234Phase 4
- A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic DermatitisWithdrawnNCT05240300Phase 1/2
- A Study to Assess the Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quantification in a Subset of Participants From PEDISTAD Study (OBS15333; NCT03687359)CompletedNCT05235724
- A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin AreaCompletedNCT05226143Not applicable
- Immunomodulation by OM-85 (Broncho-Vaxom) in Early ADTerminatedNCT05222516Phase 2
- A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf CountriesCompletedNCT05214326
- Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT05203380
- The Study of CM326 in Patients With Moderate-to-severe Atopic DermatitisStatus unknownNCT05186922Phase 1/2
- Skin Care Strategies for Neonatal Jaundice Phototherapy to Prevent Atopic Dermatitis in Moderate and Severe InfantsStatus unknownNCT05178433Not applicable
- Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic DiseaseCompletedNCT05177744
- Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic DermatitisCompletedNCT05158023Phase 2
- Effects of Abrocitinib Treatment on Skin Barrier FunctionCompletedNCT05140239
- A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World SettingActive, not recruitingNCT05139836
- Scratching Validation StudyCompletedNCT05137093
- Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic DermatitisStatus unknownNCT05136261Phase 3
- Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic DermatitisCompletedNCT05114889Phase 1
- Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune ModulationCompletedNCT05098821
- A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin ParticipantsCompletedNCT05094700Not applicable
- Exploratory Study to Evaluate the Application of NLAC Cream in Adults With Atopic DermatitisStatus unknownNCT05092464Not applicable
- Creation of a Shared Medical Decision-making Tool for Atopic DermatitisStatus unknownNCT05090982
- The Role of Genetic Factors in the Development of Atopic Dermatitis in the Kazakh PopulationCompletedNCT05090631
- A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic DermatitisCompletedNCT05081557
- Results in Real Clinical Practice of Treatment of Moderate-severe Atopic DermatitisStatus unknownNCT05078294
- A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion in Adults of Atopic Dermatitis.CompletedNCT05062213Not applicable
- Evaluate Efficacy of FB825 in Adults With Atopic DermatitisCompletedNCT05059509Phase 2
- A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic DermatitisCompletedNCT05057351Not applicable
- Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically AdvisableWithdrawnNCT05056779Phase 3
- Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic DermatitisTerminatedNCT05048056Phase 2
- Study of Ruxolitinib Cream in Children With Atopic DermatitisCompletedNCT05034822Phase 1
- Assessing SleeP IN Infants With Atopic Dermatitis by Longitudinal EvaluationStatus unknownNCT05031754
- A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)CompletedNCT05029895
- China Atopic Dermatitis Registry StudyStatus unknownNCT05023668
- Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis PatientsCompletedNCT05019209Not applicable
- Comparison of JW-100 and EUCRISA for the Treatment of Atopic DermatitisWithdrawnNCT05016284Phase 3
- Evaluation of the Efficacy of Topialyse Baume barrière on Atopic DermatisWithdrawnNCT05006300Not applicable
- Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD)Status unknownNCT05004324Phase 3
- Allergic Disease Onset Prevention StudyCompletedNCT05003804Phase 1/2
- The Effectiveness of a Topical Palmitoylethanolamide (PEA) Formulation (Levagen+) for Reducing Symptoms of EczemaCompletedNCT05003453Phase 2/3
- Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic DermatitisCompletedNCT04976868
- Ocular Comorbidity in Atopic DermatitisActive, not recruitingNCT04973384
- Using a Telemedicine Approach in a Genome-wide Association Study of Atopic Dermatitis - Searching for Novel Biomarkers in Clinically Relevant PhenotypesWithdrawnNCT04965233
- Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic DermatitisTerminatedNCT04955951
- A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion and a Lip Moisturizer in Adults of Atopic Dermatitis.WithdrawnNCT04950374Not applicable
- Study on the Correlation Between Intestinal Microecology and Allergic Diseases in ChildrenStatus unknownNCT04938700Phase 4
- Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 StudyTerminatedNCT04936113Phase 2
- Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic DermatitisCompletedNCT04927572Phase 1/2
- Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild AsthmaCompletedNCT04927195Phase 1
- Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of LifeCompletedNCT04900948Phase 4
- Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in ChildhoodStatus unknownNCT04895423Phase 4
- Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)CompletedNCT04893941Phase 1/2
- The Study of CM310 in Patients With Atopic DermatitisCompletedNCT04893707Phase 2
- NMF-CsA-Dupi TrialStatus unknownNCT04878770Not applicable
- Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisCompletedNCT04875169Phase 3